טוען...
Prognostic Variables in Low and High Risk Stage III Colon Cancers Treated in Two Adjuvant Chemotherapy Trials
BACKGROUND: Stratification of patients with stage III colon cancer into low (T(1–3)N(1)) and high (T(4) and/or N(2)) risk groups is used to guide the duration of adjuvant chemotherapy. We determined the relative contribution of clinical and molecular features to survival by risk group. MATERIALS &am...
שמור ב:
| הוצא לאור ב: | Eur J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7855426/ https://ncbi.nlm.nih.gov/pubmed/33341444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2020.11.016 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|